Get started
Author

Odile Y. Leroy

Reduced Response to Multiple Vaccines Sharing Common Protein Epitopes That Are Administered Simultaneously to Infants
1998 · Ron Dagan, Juhani Eskola, et al. · Infection and Immunity · 241
PDF
Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid
1997 · RON DAGAN, MARIE MUALLEM, et al. · The Pediatric Infectious Disease Journal · 217
Child mortality after high-titre measles vaccines: prospective study in Senegal
1991 · M. Garenne, O. Leroy, et al. · The Lancet · 177
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria
2019 · Benjamin Mordmüller, Mihály Sulyok, et al. · Clinical Infectious Diseases · 154
PDF
Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen
2005 · Régine Audran, Michel Cachat, et al. · Infection and Immunity · 148
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
2015 · Caroline Ogwang, Domtila Kimani, et al. · Science Translational Medicine · 131
Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory
1998 · HEIDI ÅHMAN, HELENA KÄYHTY, et al. · The Pediatric Infectious Disease Journal · 131
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
2020 · Sodiomon B Sirima, Laura Richert, et al. · The Lancet Infectious Diseases · 124
Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens
1997 · RON DAGAN, RIMMA MELAMED, et al. · The Pediatric Infectious Disease Journal · 120
Safety and immunogenicity of GMZ2 — a MSP3–GLURP fusion protein malaria vaccine candidate
2009 · Meral Esen, Peter G. Kremsner, et al. · Vaccine · 112
Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial
2006 · Cornelus C. Hermsen, Danielle F. Verhage, et al. · Vaccine · 92
Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
2008 · Meta Roestenberg, Ed Remarque, et al. · PLoS ONE · 91
International differences in clinical patterns of diarrhoeal deaths: a comparison of children from Brazil, Senegal, Bangladesh, and India.
1993 · C G Victora, S R Huttly, et al. · PubMed · 81
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
2018 · Alfred B. Tiono, Issa Nébié, et al. · PLoS ONE · 79
PDF
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon
2010 · Benjamin Mordmüller, Katja Szywon, et al. · Vaccine · 70
The safety and use of canarypox vectored vaccines.
1995 · S A Plotkin, M Cadoz, et al. · PubMed · 68
Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid1Presented in part at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 1995 and the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, September 1996.1
1999 · Heidi Åhman, Helena Käyhty, et al. · Vaccine · 67
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
2016 · Muhammed O Afolabi, Alfred B Tiono, et al. · Molecular Therapy · 63
PDF
Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults
2001 · Tomi Wuorimaa, Helena Käyhty, et al. · Vaccine · 61
Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid
2000 · Maija Korkeila, Hannele Lehtonen, et al. · Vaccine · 59
Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers
2001 · TOMI WUORIMAA, RON DAGAN, et al. · The Pediatric Infectious Disease Journal · 58
Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa
2006 · Sodiomon B. Sirima, Issa Nébié, et al. · Vaccine · 55
Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal
2016 · Victorine A. Mensah, Aly Gueye, et al. · PLoS ONE · 52
PDF
The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine
2015 · Morten A. Nielsen, Mafalda Resende, et al. · PLoS ONE · 48
PDF
Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175
2015 · Chetan E. Chitnis, Paushali Mukherjee, et al. · PLoS ONE · 47
PDF
Works count: 94
Citation count: 3,332
H-index: 34
I10-index: 51
Year
Topic
Type